Get the Stockscreener App
6.20
0.81%
0.05
Precipio Inc stock is traded at $6.20, with a volume of 1,630.
It is up +0.81% in the last 24 hours and down -8.75% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$6.15
Open:
$6.1794
24h Volume:
1,630
Relative Volume:
0.17
Market Cap:
$9.12M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-0.6739
EPS:
-9.2
Net Cash Flow:
$-2.65M
1W Performance:
-0.96%
1M Performance:
-8.75%
6M Performance:
+6.90%
1Y Performance:
-26.80%
1-Day Range:
$6.1794
$6.38
1-Week Range:
$6.14
$6.48
52-Week Range:
$4.31
$8.7423
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Precipio Inc Stock (PRPO) Latest News
Trend Tracker for (PRPO) - Stock Traders Daily
(PRPO) Trading Report - Stock Traders Daily
Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation Subtyping - The Manila Times
PRPO Stock Earnings: Precipio Reported Results for Q2 2024 - MSN
Long Term Trading Analysis for (PRPO) - Stock Traders Daily
Precipio (NASDAQ:PRPO) Shares Pass Above Two Hundred Day Moving Average of $5.85 - Defense World
When the Price of (PRPO) Talks, People Listen - Stock Traders Daily
Precipio Incentivizes Staff with Strategic Stock Option Repricing - TipRanks
Precipio Announces Employee Stock Option Plan Repricing - ForexTV.com
Precipio Announces Stock Option Repricing for Employees - Investing.com
Zacks Initiates Coverage of Precipio With Outperform Recommendation - Yahoo Finance
Objective long/short (PRPO) Report - Stock Traders Daily
Head-To-Head Comparison: Prenetics Global (NASDAQ:PRE) vs. Precipio (NASDAQ:PRPO) - Defense World
Precipio Inc (PRPO) Q2 2024 Earnings Call Transcript Highlights: Revenue Growth and Path to Profitability - GuruFocus.com
Market Might Still Lack Some Conviction On Precipio, Inc. (NASDAQ:PRPO) Even After 29% Share Price Boost - Simply Wall St
Precipio, Inc. (NASDAQ:PRPO) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Precipio Q2 2024 results show progress towards profitability By Investing.com - Investing.com Canada
Precipio (NASDAQ:PRPO) Stock Price Passes Below 200-Day Moving Average of $5.85 - Defense World
Precipio Second Quarter 2024 Earnings: US$0.83 loss per share (vs US$1.88 loss in 2Q 2023) - Simply Wall St
Precipio Announces Q2-2024 Shareholder Update Call - ForexTV.com
Hematologic Malignancies Testing Markets, 2023-2033: - GlobeNewswire
Financial Survey: Precipio (NASDAQ:PRPO) vs. Prenetics Global (NASDAQ:PRE) - Defense World
(PRPO) Trading Advice - Stock Traders Daily
Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven - StockTitan
Precipio reports unaudited CBFO for Q2 was $0.3M - TipRanks
Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 - ForexTV.com
Precipio (NASDAQ:PRPO) Share Price Crosses Below 200-Day Moving Average of $6.00 - Defense World
Precipio (NASDAQ:PRPO) Share Price Passes Below Two Hundred Day Moving Average of $6.08 - Defense World
Precipio, Inc. (NASDAQ:PRPO) Short Interest Down 14.3% in June - Defense World
Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average of $6.14 - Defense World
Precipio (NASDAQ:PRPO) Stock Price Passes Below Two Hundred Day Moving Average of $6.21 - Defense World
PRPOPrecipio, Inc. Latest Stock News & Market Updates - StockTitan
Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future - Yahoo Canada Sports
(PRPO) Trading Signals - Stock Traders Daily
Precipio says pathology revenue 'heading back towards' breakeven pointTipRanks.com - TipRanks
Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders - GlobeNewswire Inc.
Precipio faces $100,000 cost if shareholder meeting delayed By Investing.com - Investing.com UK
Precipio on track for mid-year breakeven after setbacks By Investing.com - Investing.com
Precipio Provides Status Update on Current Business Matters - StockTitan
Here's Why Shareholders May Want To Be Cautious With Increasing Precipio, Inc.'s (NASDAQ:PRPO) CEO Pay Packet - Simply Wall St
It's Probably Less Likely That Precipio, Inc.'s (NASDAQ:PRPO) CEO Will See A Huge Pay Rise This Year - Yahoo Finance
Precipio (NASDAQ:PRPO) Stock Passes Below 200-Day Moving Average of $6.32 - Defense World
(PRPO) Investment Analysis and Advice - Stock Traders Daily
Precipio (NASDAQ:PRPO) shareholders have endured a 44% loss from investing in the stock three years ago - Yahoo Eurosport UK
Precipio (NASDAQ:PRPO) Shares Cross Below 200 Day Moving Average of $6.39 - Defense World
Cancer Diagnostics Market to Grow at a 7% CAGR, Driven by Technological Advancements - PharmiWeb.com
(PRPO) Investment Report - Stock Traders Daily
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.50% - MSN
Precipio (NASDAQ:PRPO) Stock Crosses Above Two Hundred Day Moving Average of $6.50 - Defense World
PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024 - MSN
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):